William Bertrand
2021
In 2021, William Bertrand earned a total compensation of $1.8M as Chief Operating Officer at Adaptimmune Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,265 |
|---|---|
| Option Awards | $1,069,101 |
| Salary | $456,760 |
| Other | $35,062 |
| Total | $1,756,188 |
Bertrand received $1.1M in option awards, accounting for 61% of the total pay in 2021.
Bertrand also received $195.3K in non-equity incentive plan, $456.8K in salary and $35.1K in other compensation.
Rankings
In 2021, William Bertrand's compensation ranked 6,564th out of 12,415 executives tracked by ExecPay. In other words, Bertrand earned more than 47.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,564 out of 12,415 | 47th |
Division Manufacturing | 2,825 out of 5,505 | 49th |
Major group Chemicals And Allied Products | 1,244 out of 2,375 | 48th |
Industry group Drugs | 1,109 out of 2,096 | 47th |
Industry Biological Products, Except Diagnostic Substances | 264 out of 449 | 41st |
Pay ratio
| William Bertrand's Pay | $1,756,188 |
|---|---|
| Median Employee's Pay | $126,493 |
| Pay Ratio | 14to 1 |
In 2021, the annual total compensation of William Bertrand was $1,756,188.
The annual total compensation of the median employee at Adaptimmune Therapeutics was $126,493.
The ratio of William Bertrand's pay to the pay of median employee was therefore 14 to one.
Source: SEC filing on April 21, 2022.
Bertrand's colleagues
We found four more compensation records of executives who worked with William Bertrand at Adaptimmune Therapeutics in 2021.